Pilot and Feasibility Study (P/FS) Program Guidelines
ELIGIBILITY
Individuals who have full-time instructional, clinical, or research faculty positions are eligible to apply as Principal Investigators of P/FS grant proposals. Eligible applicants must be: a) new investigators beginning careers in diabetes-related research (ie research relevant to diabetes, its complications, or related endocrine and metabolic disorders); b) established investigators in areas other than diabetes who wish to focus their expertise on a problem in diabetes-related research; or c) established investigators in diabetes-related research who wish to take an entirely new direction in their diabetes-related research. This new direction cannot be an extension of the research currently being undertaken by the applicant.
APPLICATIONS
Proposals should be for one year of support, with requested funding up to $50,000. P/FS funds may not be used to support the salary of the Principal Investigator, for travel expenses, or to purchase equipment (i.e., durable items costing over $5,000). P/FS support can be applied to the salary of a study coordinator or research assistant and supplies.
Each proposal will be peer reviewed by recognized experts in the area of the proposal from non-participating university investigators from the United States and abroad. The results of the review will be weighed by the MDRTC/MCDTR Grants Program Advisory Council at its meeting in early November 2011. It is anticipated that the 4-5 most meritorious P/FS projects will be funded in December 2011.
Applications must be prepared using the new 2011-12 MDRTC P/F application. An application form can be obtained by calling Barbara Hawkins at 734-763-2561 or emailing (hawkinsb@umich.edu).
Proposals should be for one year of support, with requested funding up
to $50,000.
Application Due Date: 5 PM Tuesday, August 2, 2011
MDRTC/MCDTR PILOT and FEASIBILITY AWARD TERMS
1) Awardees are required to inform the MDRTC/MCDTR if the P/FS grant receives external funding during the project period.
2) A final progress report is due one month after the close of the project period. The one page report must contain a synopsis of scientific progress; a list of resulting collaborations, publications, grants; and a description of the relationship of the project to MDRTC/MCDTR Core use.
3) For the following 5 years, awardees must provide annual updates concerning other support, publications, and research activities related to the P/FS grant award, even if they leave the institution.
4) Biomedical awardees must attend the MDRTC Winter Symposium (generally held in March or April each year) and present a poster on their research.
5)Publications resulting from the P/FS grant award must acknowledge grant support from the MDRTC/MCDTR with the statement:
“This work utilized ____ Core(s) of the Michigan Diabetes Research and Training Center funded by NIH DK020572 from the National Institute of Diabetes and Digestive and Kidney Diseases.”
or
“This work utilized the ____ Core(s) of the Michigan Center for Diabetes Translational Research funded by NIH DKxx (number not yet known) from the National Institute of Diabetes and Digestive and Kidney Diseases.”
